Front Page
August 26, 2026
7-OH: What is it? Why do people use it? What medical approaches can help?
Caleb Banta-Green, PhD, MPH, MSW; Mark Duncan, MD; Chris Buresh, MD, MPH; Maureen Oscadal, RN, MPH; Tom Hutch, MD; Mandy Sladky, MSN, RN Key points We encourage people who have questions about 7-OH to talk to their healthcare provider and we encourage providers to call our Psychiatry Consult Line if they have any questions. —…
New Shared Decision-Making Tools for Alcohol Use Disorder, Developed As Part of ADAI’s Work to Implement WA Senate Bill 6228
ADAI is excited to share two new FREE resources to support shared decision-making for alcohol use disorder (AUD): The tools were developed through a collaboration with the UW Addictions, Drug & Alcohol Institute, the UW Division of Pulmonary, Critical Care, and Sleep Medicine, and the American Society of Addiction Medicine. Funding for the tools was…
REGISTRATION OPEN: 2026 ADAI Symposium on Cannabinoid Hyperemesis Syndrome (Sept. 18)
The Dose Makes the Poison: Cannabinoid Hyperemesis Syndrome Goes Mainstream September 18, 2026 | 9:00am – 4:00pm PT Attend virtually or in person at the UW Tower Auditorium. View program | Register | CME credits info Cannabinoid Hyperemesis Syndrome (CHS) is becoming increasingly visible in clinical settings, but many providers are navigating diagnosis, treatment, and patient communication without clear guidance. In a recent survey of Washington State healthcare providers, 70%…
REGISTRATION OPEN: First Responder Wellness Summit (September 23, 2026)
Caring for Ourselves During the Overdose CrisisSeptember 23, 2026 | 8:00am-3:45pm PT | Register here Location: The Hub Ballroom at the University of Washington | 4001 E. Stevens Way NE, Seattle, WA First responders regularly face complex, high-impact situations that can take a toll over time, particularly as calls around substance use and drug overdose have…
August 18, 2026
ADAI is Hiring! Administrative Assistant (50% FTE)
The UW Addictions, Drug & Alcohol Institute (ADAI) is seeking a part-time Administrative Assistant (50% FTE) to help support operations that contribute to our mission to advance research, policy, and practice in order to improve the lives of people and communities affected by alcohol and drug use and addiction. Reporting to the ADAI Director and faculty leadership, the…
August 13, 2026
What You Say Matters More Than You Think: A Toolkit to Help Reduce Stigma in Healthcare & Beyond
Substance use disorder is a chronic medical condition, but the language surrounding it often tells a different story. “Addict,” “junkie,” “drug-seeker” – stigma happens when people see a label before they see a person and let that label influence their interactions. This campaign and toolkit, developed by ADAI Information Team summer intern Karen Da Silva,…
August 10, 2026
Northwest ATTC Webinar: Recovery Coaching for Faith-Based Communities (Aug. 26, 12pm PT)
Just in time for Recovery Month, join the Northwest ATTC at ADAI for their next webinar, featuring presenters Pete Villanueva and Becky Gonzalez from Recovery Cafe of Clark County! This session will introduce you to “the power” of Recovery Coaching, a compassionate, person-centered approach that meets individuals where they are. “People are in recovery if…
July 22, 2026
ADAI/SOR Webinar: Involuntary SUD Treatment in Washington: When & How? (August 5, 2026, 12-1:30pm PT)
The State Opioid Response (SOR) team at ADAI has been hosting an ongoing series called “Frontline Conversations: Advancing SUD Care in Clinical Practice,” which explores emerging practices in the care of people living with substance use disorder (SUD). In their third session, August 5, 2026 (12-1:30pm PT), they’ll be discussing Involuntary SUD Treatment in Washington…
July 17, 2026
ADAI Small Grants: Fall Cycle is Open; Apply by September 9, 2026!
ADAI works to stimulate and facilitate UW research on alcohol and drug use and addiction through its Small Grants research program, which awards funds to UW researchers for pilot studies and developmental research. Applications for the fall cycle are now being accepted; apply by 5pm PT September 9, 2026! Research funded through the small grants program has…
July 10, 2026
ATTC/CTN Webinar July 29: Advising Patients on Buprenorphine Treatment Duration for Opioid Use Disorder (1.5 CME/CE available!)
Buprenorphine is a life-saving treatment for opioid use disorder, yet many people stop treatment earlier than recommended, either by choice or because they face barriers to ongoing care. In this webinar, sponsored by the Northwest ATTC, Pacific Southwest ATTC, and the Western States Node of the NIDA Clinical Trials Network, experts Ingrid Binswanger, MD, MPH,…
Next page
